"Leukemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
Descriptor ID |
D007938
|
MeSH Number(s) |
C04.557.337
|
Concept/Terms |
Leukemia- Leukemia
- Leukemias
- Leucocythaemia
- Leucocythaemias
- Leucocythemia
- Leucocythemias
|
Below are MeSH descriptors whose meaning is more general than "Leukemia".
Below are MeSH descriptors whose meaning is more specific than "Leukemia".
This graph shows the total number of publications written about "Leukemia" by people in this website by year, and whether "Leukemia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 20 | 10 | 30 |
1995 | 14 | 5 | 19 |
1996 | 20 | 5 | 25 |
1997 | 10 | 5 | 15 |
1998 | 6 | 3 | 9 |
1999 | 6 | 6 | 12 |
2000 | 11 | 4 | 15 |
2001 | 12 | 5 | 17 |
2002 | 9 | 6 | 15 |
2003 | 8 | 8 | 16 |
2004 | 24 | 7 | 31 |
2005 | 14 | 9 | 23 |
2006 | 18 | 4 | 22 |
2007 | 17 | 2 | 19 |
2008 | 19 | 7 | 26 |
2009 | 22 | 4 | 26 |
2010 | 22 | 4 | 26 |
2011 | 17 | 8 | 25 |
2012 | 23 | 8 | 31 |
2013 | 19 | 3 | 22 |
2014 | 13 | 7 | 20 |
2015 | 12 | 9 | 21 |
2016 | 25 | 2 | 27 |
2017 | 22 | 6 | 28 |
2018 | 21 | 3 | 24 |
2019 | 12 | 5 | 17 |
2020 | 15 | 2 | 17 |
2021 | 11 | 1 | 12 |
2022 | 15 | 2 | 17 |
2023 | 18 | 0 | 18 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukemia" by people in Profiles.
-
Invasive fusariosis in patients with leukaemia in the era of mould-active azoles: increasing incidence, frequent breakthrough infections and lack of improved outcomes. J Antimicrob Chemother. 2024 Feb 01; 79(2):297-306.
-
miR-142: A Master Regulator in Hematological Malignancies and Therapeutic Opportunities. Cells. 2023 12 30; 13(1).
-
Traditional Medicare or Medicare Advantage? The Leukemia and Cancer Perspective. Mayo Clin Proc. 2024 Jan; 99(1):15-21.
-
Early mortality after chemotherapy as a quality indicator-the leukemia perspective. Blood Cancer J. 2023 12 01; 13(1):176.
-
Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II study. Haematologica. 2023 Dec 01; 108(12):3454-3459.
-
Counts, incidence rates, and trends of pediatric cancer in the United States, 2003-2019. J Natl Cancer Inst. 2023 11 08; 115(11):1337-1354.
-
Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41. Blood Adv. 2023 10 24; 7(20):6092-6107.
-
Excessive concentrations of kinase inhibitors in translational studies impede effective drug repurposing. Cell Rep Med. 2023 10 17; 4(10):101227.
-
Deleterious heteroplasmic mitochondrial mutations are associated with an increased risk of overall and cancer-specific mortality. Nat Commun. 2023 09 30; 14(1):6113.
-
The E3 ligase DTX2 inhibits RUNX1 function by binding its C terminus and prevents the growth of RUNX1-dependent leukemia cells. FEBS J. 2023 11; 290(21):5141-5157.